These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

203 related items for PubMed ID: 477026

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. [Antibodies: biology and clinical use].
    De Martino M, Rossi ME, Vierucci A.
    Ann Sclavo Collana Monogr; 1984; 1(1):1-305. PubMed ID: 6546001
    [No Abstract] [Full Text] [Related]

  • 23. Use of intravenous pH 4.0 treated gamma globulin in humoral immunodeficiency disease.
    Cunningham-Rundles C, Smithwick EM, Siegal FP, Day NK, Lion A, O'Malley J, Barandun S, Good RA.
    Birth Defects Orig Artic Ser; 1983; 19(3):201-3. PubMed ID: 6197105
    [No Abstract] [Full Text] [Related]

  • 24. Pharmacokinetics of subcutaneous immunoglobulin and their use in dosing of replacement therapy in patients with primary immunodeficiencies.
    Berger M, Rojavin M, Kiessling P, Zenker O.
    Clin Immunol; 2011 May; 139(2):133-41. PubMed ID: 21353644
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Intravenous immunoglobulin: new clinical applications.
    Steele RW, Burks AW, Williams LW.
    Ann Allergy; 1988 Feb; 60(2):89-94. PubMed ID: 2829663
    [Abstract] [Full Text] [Related]

  • 27. Efficacy of intravenous gammaglobulin for immunoglobulin G subclass and/or antibody deficiency in adults.
    Abdou NI, Greenwell CA, Mehta R, Narra M, Hester JD, Halsey JF.
    Int Arch Allergy Immunol; 2009 Feb; 149(3):267-74. PubMed ID: 19218820
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Efficacy of a new intravenous immunoglobulin preparation in primary immunodeficient patients.
    Ochs HD, Lee ML, Fischer SH, Kingdon HS, Wedgwood RJ.
    Clin Ther; 1987 Feb; 9(5):512-22. PubMed ID: 3117369
    [Abstract] [Full Text] [Related]

  • 33. Immunoglobulin and immune complex levels in Nigerians with acute lymphoblastic leukaemia.
    Okpala IE, Salimonu LS.
    Afr J Med Med Sci; 1994 Jun; 23(2):171-6. PubMed ID: 7625307
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. [Use of intravenous immunoglobulins in pediatrics].
    Duse M, Plebani A, Crispino P, Ugazio AG.
    Pediatr Med Chir; 1991 Jun; 13(2):117-25. PubMed ID: 1896376
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Immunoglobulin replacement therapy.
    Sorensen RU, Polmar SH.
    Ann Clin Res; 1987 Jun; 19(4):293-304. PubMed ID: 3314655
    [No Abstract] [Full Text] [Related]

  • 39. Estimated protective effectiveness of intramuscular immune serum globulin post-exposure prophylaxis during a measles outbreak in British Columbia, Canada, 2014.
    Bigham M, Murti M, Fung C, Hemming F, Loadman S, Stam R, Van Buynder P, Lem M.
    Vaccine; 2017 May 09; 35(20):2723-2727. PubMed ID: 28392140
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 11.